Abstract
We generated transgenic mice bearing a tamoxifen-dependent Cre recombinase expressed under the control of the dopamine-β-hydroxylase promoter. By crossing to the ROSA26 reporter mice we show that tamoxifen-induced Cre recombinase in adult mice specifically activates β-galactosidase expression in differentiated noradrenergic neurons of the central and peripheral nervous system. Tamoxifen application in adult mice did not induce β-galactosidase activity in parasympathetic neurons that transiently express DBH during development. Thus, this transgenic mouse line represents a valuable tool to study gene function in mature noradrenergic neurons by conditional inactivation. © 2011 Wiley Periodicals, Inc.
Author supplied keywords
Cite
CITATION STYLE
Stubbusch, J., Majdazari, A., Schmidt, M., Schütz, G., Deller, T., & Rohrer, H. (2011). Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT. Genesis, 49(12), 935–941. https://doi.org/10.1002/dvg.20773
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.